Cargando…

Zebrafish as an Animal Model for Drug Discovery in Parkinson’s Disease and Other Movement Disorders: A Systematic Review

Movement disorders can be primarily divided into hypokinetic and hyperkinetic. Most of the hypokinetic syndromes are associated with the neurodegenerative disorder Parkinson’s disease (PD). By contrast, hyperkinetic syndromes encompass a broader array of diseases, including dystonia, essential tremo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaz, Rita L., Outeiro, Tiago F., Ferreira, Joaquim J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992294/ https://www.ncbi.nlm.nih.gov/pubmed/29910763 http://dx.doi.org/10.3389/fneur.2018.00347

Ejemplares similares

The Role of Alpha-Synuclein and Other Parkinson’s Genes in Neurodevelopmental and Neurodegenerative Disorders
por: Morato Torres, C. Alejandra, et al.
Publicado: (2020)

More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy
por: Flores-Leon, Manuel, et al.
Publicado: (2023)

Developing highER-throughput zebrafish screens for in-vivo CNS drug discovery
por: Stewart, Adam Michael, et al.
Publicado: (2015)

Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved
por: Vasili, Eftychia, et al.
Publicado: (2019)

Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson’s Disease and Other Synucleinopathies
por: Skorvanek, Matej, et al.
Publicado: (2018)

Stem Cell Therapies in Movement Disorders: Lessons from Clinical Trials
por: Marsili, Luca, et al.
Publicado: (2023)

Modeling spinal locomotor circuits for movements in developing zebrafish
por: Roussel, Yann, et al.
Publicado: (2021)

Editorial: Insights into Parkinson's disease and aging related movement disorders
por: Petersen, Robert B., et al.
Publicado: (2023)

On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson’s and Huntington’s Disease
por: Troncoso-Escudero, Paulina, et al.
Publicado: (2020)

Minor hallucinations in Parkinson’s disease with probable rapid eye movement sleep behavior disorder
por: Jiang, Yinyin, et al.
Publicado: (2023)

Targeting GTPases in Parkinson’s disease: comparison to the historic path of kinase drug discovery and perspectives
por: Hong, Lin, et al.
Publicado: (2014)

Machine learning discriminates a movement disorder in a zebrafish model of Parkinson's disease
por: Hughes, Gideon L., et al.
Publicado: (2020)

Larval Zebrafish as a Model for Mechanistic Discovery in Mental Health
por: Tan, Jazlynn Xiu Min, et al.
Publicado: (2022)

Measurement tools to assess activities of daily living in patients with Parkinson’s disease: A systematic review
por: Bouça-Machado, Raquel, et al.
Publicado: (2022)

End of OSLER Test Sessions in Parkinson’s Disease do not Correspond to True Sleep Onset: Results from an Exploratory Study
por: Neutel, Dulce, et al.
Publicado: (2015)

Editorial: Sound, Music, and Movement in Parkinson’s Disease
por: Bieńkiewicz, Marta M. N., et al.
Publicado: (2016)

Transcranial sonography in differential diagnosis of Parkinson disease and other movement disorders
por: Wang, Li-Shu, et al.
Publicado: (2021)

Editorial on Special Topic: Sirtuins in Metabolism, Aging, and Disease
por: Kazantsev, Aleksey G., et al.
Publicado: (2012)

Espresso Coffee for the Treatment of Somnolence in Parkinson’s Disease: Results of n-of-1 Trials
por: Ferreira, Joaquim J., et al.
Publicado: (2016)

Parkinson’s disease model in zebrafish using intraperitoneal MPTP injection
por: Omar, Noor Azzizah, et al.
Publicado: (2023)

A Novel Microfluidic Cell Co-culture Platform for the Study of the Molecular Mechanisms of Parkinson's Disease and Other Synucleinopathies
por: Fernandes, João T. S., et al.
Publicado: (2016)

Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders
por: Ingelsson, Martin
Publicado: (2016)

Pharmacogenetics of Antipsychotic-Induced Movement Disorders as a Resource for Better Understanding Parkinson’s Disease Modifier Genes
por: Greenbaum, Lior, et al.
Publicado: (2015)

Alterations of Brain Structural Network in Parkinson’s Disease With and Without Rapid Eye Movement Sleep Behavior Disorder
por: Guo, Tao, et al.
Publicado: (2018)

Different Perivascular Space Burdens in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease
por: Si, Xiao-li, et al.
Publicado: (2020)

Sleep and Autonomic Manifestations in Parkinson’s Disease Complicated With Probable Rapid Eye Movement Sleep Behavior Disorder
por: Fujita, Hiroaki, et al.
Publicado: (2022)

SNCA rs3910105 Is Associated With Development of Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s Disease
por: Yang, Nan-nan, et al.
Publicado: (2022)

Protein phosphorylation in neurodegeneration: friend or foe?
por: Tenreiro, Sandra, et al.
Publicado: (2014)

Eye Movements in Parkinson’s Disease and Inherited Parkinsonian Syndromes
por: Pretegiani, Elena, et al.
Publicado: (2017)

Saccadic and Postsaccadic Disconjugacy in Zebrafish Larvae Suggests Independent Eye Movement Control
por: Chen, Chien-Cheng, et al.
Publicado: (2016)

The associations of cerebrospinal fluid biomarkers with cognition, and rapid eye movement sleep behavior disorder in early Parkinson’s disease
por: Tao, Mingzhu, et al.
Publicado: (2022)

Psychostimulants and Movement Disorders
por: Asser, Andres, et al.
Publicado: (2015)

Kinematics of the Reach-to-Grasp Movement in Vascular Parkinsonism: A Comparison with Idiopathic Parkinson’s Disease Patients
por: Parma, Valentina, et al.
Publicado: (2014)

A Perspective on Wearable Sensor Measurements and Data Science for Parkinson’s Disease
por: Matias, Ricardo, et al.
Publicado: (2017)

Social learning in humans and other animals
por: Gariépy, Jean-François, et al.
Publicado: (2014)

The Influence of Movement Initiation Deficits on the Quantification of Retention in Parkinson’s Disease
por: Pendt, Lisa K., et al.
Publicado: (2012)

Eye movement control during visual pursuit in Parkinson’s disease
por: Wu, Chia-Chien, et al.
Publicado: (2018)

Stereopsis and Eye Movement Abnormalities in Parkinson’s Disease and Their Clinical Implications
por: Ba, Fang, et al.
Publicado: (2022)

Glucocerebrosidase Involvement in Parkinson Disease and Other Synucleinopathies
por: Almeida, Maria do Rosário
Publicado: (2012)

Abnormal Eye Movements in Parkinsonism and Movement Disorders
por: Jung, Ileok, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cu6j4ec98ren3unvhvu91v96v6